Work

A phase I/II trial of DTIC and dasatinib in metastatic melanoma.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.8532

Authors: A. P. Algazi, J. S. Weber, S. Andrews, P. Urbas, E. Arimura, J. Hwang, V. K. Sondak, B. Bastian, A. Daud

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2256269304

Cites:

Cited by: 2

Related to: 10